Alternative splicing: an emerging topic in molecular and clinical oncology

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Alternative pre-messenger RNA (mRNA) splicing is a fundamental biological process enabling a single gene to produce multiple protein isoforms.
• Dysregulation of alternative splicing is implicated in the pathogenesis of various diseases, notably cancer.
• Alterations in splicing patterns of cancer-related genes arise from mutations in regulatory elements or changes in splicing machinery.

Purpose of the Study:

• To review the mechanisms of aberrant alternative splicing in cancer.
• To discuss the biological consequences of altered splicing in cancer-related genes.
• To explore the potential of alternative splicing as a source for cancer biomarkers and therapeutics.

Main Methods:

• Literature review of studies on alternative splicing in cancer.
• Analysis of molecular mechanisms driving aberrant splicing.
• Examination of biological impacts of splicing alterations in cancer genes.

Main Results:

• Cancer-specific alternative splicing is driven by genetic mutations and regulatory machinery changes.
• Altered splicing of key cancer genes leads to diverse and potentially antagonistic protein functions.
• Aberrant splicing contributes to cancer development and progression.

Conclusions:

• Understanding cancer-specific alternative splicing mechanisms is crucial for cancer research.
• Alternative splicing alterations present opportunities for developing novel diagnostic, prognostic, and therapeutic strategies.
• Targeting aberrant splicing pathways may offer new avenues for cancer treatment.